Development of Real-time Imaging Method of Protein Tyrosine Phosphorylation
蛋白质酪氨酸磷酸化实时成像方法的开发
基本信息
- 批准号:09670115
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have tried to develop fluorescence probes for imaging of protein tyrosine phosphorylation. First, the genes coding SH2 domains in Grb2/Ash and PLCγ1 were fused with pEGFP-N and -C vectors (Clonetech) and the pEGFP-SH2 vectors were produced for the expression of EGFP-SH2. Four conjugated proteins, showing the almost same fluorescence spectra as EGFP, have been expressed in E.Coli. The proteins could be expressed in Hela cell, RBL-2H3 cell, HegG2 cell, and so on. However, no reproducible change in the localization of the fluorescence has been observed after the treatment with the stimulants of tyrosine phosphorylation. Second, the fluorescence probes, whose fluorescence wavelength is changed by FRET between ECFP and EYFP, have been developed. The plasmids for the expression of CFP-SH2 (Grb2/Ash) -YFP, YFP-SH2 (Grb2/Ash) -CFP, and YFP-SH2 (PLCγ1) -CFP were produced. The peptides, which are recognized by the SH2 domains in EGF receptor and PDGF receptor β, and those, whose tyrosine are phosphorylated, are both chemically synthesized. The fluorescence spectrum is different between YFP-SH2 (PLCγ1) -CFP incubated with the synthesized peptide and that incubated with the phosphorylated peptide. The plasmids for the expression of the fused proteins of the polypeptide (which are designed from N-terminal and C-terminal of EGF receptor and PDGF receptor), whose tyrosine are phosphorylated, and ECFP or EYFP have been produced. The fluorescence spectrum of one (CFP- (20amino acids residue around the tyrosine residue phosphorylated in PDFG receptor) -YFP) of the fused proteins has been changed after the incubation with the homogenate debris of HeLa cell, RBL-2H3 cell and so on, in the presence of ATP and EGF (PDGF). Unfortunately, the significant change of the fluorescence of those probes following the stimulation of tyrosine phosphorylation has not been detected in the cells, yet.
我们尝试开发用于蛋白质酪氨酸磷酸化成像的荧光探针。首先,将Grb2/Ash和PLCγ1中编码SH2结构域的基因与pEGFP-N和-C载体(Clonetech)融合,并产生pEGFP-SH2载体用于表达EGFP-SH2。四种缀合蛋白在大肠杆菌中表达,显示出与 EGFP 几乎相同的荧光光谱。该蛋白可在Hela细胞、RBL-2H3细胞、HegG2细胞等细胞中表达。然而,在用酪氨酸磷酸化刺激剂处理后,没有观察到荧光定位的可重复变化。其次,开发了通过ECFP和EYFP之间的FRET改变荧光波长的荧光探针。制作了用于表达CFP-SH2(Grb2/Ash)-YFP、YFP-SH2(Grb2/Ash)-CFP和YFP-SH2(PLCγ1)-CFP的质粒。 EGF受体和PDGF受体β的SH2结构域识别的肽以及酪氨酸被磷酸化的肽都是化学合成的。与合成肽一起孵育的YFP-SH2(PLCγ1)-CFP与与磷酸化肽一起孵育的YFP-SH2(PLCγ1)-CFP的荧光光谱不同。制备了酪氨酸磷酸化的多肽融合蛋白(从EGF受体和PDGF受体的N端和C端设计)和ECFP或EYFP的表达质粒。融合蛋白之一(CFP-(PDFG受体磷酸化酪氨酸残基周围的20个氨基酸残基)-YFP)与HeLa细胞、RBL-2H3细胞等匀浆碎片在ATP和EGF(PDGF)存在下孵育后,荧光光谱发生变化。不幸的是,尚未在细胞中检测到这些探针在刺激酪氨酸磷酸化后荧光的显着变化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
川西 徹: "高速共焦点顕微鏡"細胞. 31. 14-18 (1999)
Toru Kawanishi:“高速共聚焦显微镜”细胞。 31. 14-18 (1999)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
川西 徹: "共焦点レーザー走査顕微鏡を用いた細胞内カルシウムイオンの高速高分解能画像化"日本薬理学雑誌. 112. 89-95 (1998)
Toru Kawanishi:“使用共焦激光扫描显微镜对细胞内钙离子进行高速、高分辨率成像”《日本药理学杂志》112. 89-95 (1998)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M.TAKAHASHI, Y.MISAWA, N.WATANABE, T.KAWANISHI, H.TANAKA, K.SHIGENOBU, and Y.KOBAYASHI: "Role of P-glycoprotein in human natural killer-like cell line-mediated cytotoxicity."Exp. Cell Res. 253. 396-402 (1999)
M.TAKAHASHI、Y.MISAWA、N.WATANABE、T.KAWANISHI、H.TANAKA、K.SHIGENOBU 和 Y.KOBAYASHI:“P-糖蛋白在人类自然杀伤样细胞系介导的细胞毒性中的作用。”Exp。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Toru kawanishi,Hiroki Asoh,Takashi Kato,Chikako Uneyama,Kazuhiro Toyoda,Reiko Teshima,Hideharu Ikebuchi,Hisayuki Ohata,Kazutaka Momose,Takao Hayakawa and Michihito Takahashi: "Suppression of Calcium Oscillation by Tributyltin Chloride in Cultured Rat Hepa
Toru kawanishi、Hiroki Asoh、Takashi Kato、Chikako Uneyama、Kazuhiro Toyoda、Reiko Teshima、Hideharu Ikebuchi、Hisayuki Ohata、Kazutaka Momose、Takao Hayakawa 和 Michihito Takahashi:“三丁基氯化锡对培养大鼠肝脏中钙振荡的抑制
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H.tanaka,T.Ichikawa,S.Matsui,K.Okazaki,H.Masumiya,T.Kawanishi and K.Shigenobu: "Calcium channel antagonistic effects of AH-1058,a novel antiarrythmic drug,on guinea-pig my ocardium"Res.Commun.Mol.Pathol.Pharmacol.. 104. 13-21 (1999)
H.tanaka、T.Ichikawa、S.Matsui、K.Okazaki、H.Masumiya、T.Kawanishi 和 K.Shigenobu:“新型抗心律失常药物 AH-1058 对豚鼠心心膜的钙通道拮抗作用”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KAWANISHI Toru其他文献
KAWANISHI Toru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KAWANISHI Toru', 18)}}的其他基金
Studies on molecular basis of the pharmacokinetic regulation of protein drugs consisting of immunoglobulin Fc region
免疫球蛋白Fc区蛋白药物药代动力学调控的分子基础研究
- 批准号:
18590163 - 财政年份:2006
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on molecular Mechanism of Calcium Waves Using Rapid Scanning Confocal Microscopy
快速扫描共焦显微镜研究钙波的分子机制
- 批准号:
06670131 - 财政年份:1994
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Phosphotyrosine-mimicking peptides for the inhibition of the Src Homology 2 (SH2) Domain of the Signal Transducer and Activator of Transcription 3 (STAT3)
磷酸酪氨酸模拟肽,用于抑制信号转导器和转录激活剂 3 (STAT3) 的 Src 同源 2 (SH2) 结构域
- 批准号:
10388666 - 财政年份:2017
- 资助金额:
$ 1.98万 - 项目类别:
Stat 3 SH2 domain proteomimetics
Stat 3 SH2 结构域蛋白质模拟
- 批准号:
393988-2010 - 财政年份:2010
- 资助金额:
$ 1.98万 - 项目类别:
Postgraduate Scholarships - Master's
Stat 3 SH2 domain proteomimetics
Stat 3 SH2 结构域蛋白质模拟
- 批准号:
393988-2010 - 财政年份:2010
- 资助金额:
$ 1.98万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Optimisation of peptidic non-phosphorylated inhibitors of the Grb7 SH2 domain
Grb7 SH2 结构域肽类非磷酸化抑制剂的优化
- 批准号:
DP0987761 - 财政年份:2009
- 资助金额:
$ 1.98万 - 项目类别:
Discovery Projects
Roles of SH2-Domain Proteins in Repulsive Axon Guidance by A-Ephrins
SH2 结构域蛋白在 A-Ephrins 排斥性轴突引导中的作用
- 批准号:
0548561 - 财政年份:2006
- 资助金额:
$ 1.98万 - 项目类别:
Continuing Grant
Mechanisms of SH2 domain-containing inositol 5-phosphatase 2 translocation in 3T3-L1 preadipocytes
3T3-L1前脂肪细胞中含有SH2结构域的肌醇5-磷酸酶2易位机制
- 批准号:
319559-2005 - 财政年份:2006
- 资助金额:
$ 1.98万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Mechanisms of SH2 domain-containing inositol 5-phosphatase 2 translocation in 3T3-L1 preadipocytes
3T3-L1前脂肪细胞中含有SH2结构域的肌醇5-磷酸酶2易位机制
- 批准号:
319559-2005 - 财政年份:2005
- 资助金额:
$ 1.98万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
FEASIBILITY OF SH2 DOMAIN PROFILING AS A MOLECULAR DIAGNOSTIC TOOL FOR PATIENTS
SH2 结构域分析作为患者分子诊断工具的可行性
- 批准号:
7203912 - 财政年份:2005
- 资助金额:
$ 1.98万 - 项目类别:
ANALYSIS OF A 3BP2 SH2 DOMAIN-PHOSPHOPEPTIDE COMPLEX
3BP2 SH2 结构域磷酸肽复合物的分析
- 批准号:
7182901 - 财政年份:2005
- 资助金额:
$ 1.98万 - 项目类别:
Regulation of SHIP2 (SH2 domain-containing inositol 5-phosphatase 2) by insulin versus PDGF in peradipocytes
胰岛素与 PDGF 在全脂肪细胞中对 SHIP2(含有 SH2 结构域的肌醇 5-磷酸酶 2)的调节
- 批准号:
278541-2004 - 财政年份:2004
- 资助金额:
$ 1.98万 - 项目类别:
Postgraduate Scholarships - Master's